Cost-effectiveness of rivaroxaban for the prevention of stroke in patients with non-valvular atrial fibrillation – a multinational study
Abstract
Authors
Y. Asukai N. Maniadakis D. Carcedo M. Lukac T. Evers
Y. Asukai N. Maniadakis D. Carcedo M. Lukac T. Evers
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now